# Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

> **NCT03900676** · PHASE2 · UNKNOWN · sponsor: **Vyome Therapeutics Inc.** · enrollment: 480 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** VB-1953 - 2%
- **DRUG:** VB-1953 - 0% (Vehicle)

## Key facts

- **NCT ID:** NCT03900676
- **Lead sponsor:** Vyome Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-09
- **Primary completion:** 2019-11
- **Final completion:** 2020-03
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03900676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03900676, "Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03900676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*